|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/08 | |
| A61K 38/08 | |||
| A61P 5/00 | |||
| A61P 3/14 |
| (11) | Number of the document | 3246017 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17160312.9 |
| Date of filing the European patent application | 2014-06-27 | |
| (97) | Date of publication of the European application | 2017-11-22 |
| (45) | Date of publication and mention of the grant of the patent | 2021-03-24 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201361840618 P | 2013-06-28 | US |
| (72) |
MACLEAN, Derek, US
YIN, Qun, US
|
| (73) |
Amgen Inc.,
One Amgen Center Drive Thousand Oaks, California 91320,
US
|
| (54) | STABLE LIQUID FORMULATION OF AMG 416 HCL (ETELCALCETIDE) |
| STABLE LIQUID FORMULATION OF AMG 416 HCL (ETELCALCETIDE) |